Hikma Pharmaceuticals (HKMPF) Short Interest Ratio & Short Volume → 4 Cryptos BETTER than Bitcoin (From True Market Insiders) (Ad) Free HKMPF Stock Alerts $24.50 +2.17 (+9.72%) (As of 05/3/2024) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestStock AnalysisAnalyst ForecastsChartDividendHeadlinesShort Interest Hikma Pharmaceuticals Short Interest DataCurrent Short Volume1,849,700 sharesPrevious Short Volume1,741,900 sharesChange Vs. Previous Month+6.19%Dollar Volume Sold Short$41.30 millionShort Interest Ratio / Days to Cover9,248.5Last Record DateApril 30, 2024Outstanding Shares220,230,000 sharesPercentage of Shares Shorted0.84%Today's Trading Volume200 sharesAverage Trading Volume671 sharesToday's Volume Vs. Average30% Short Selling Hikma Pharmaceuticals ? Sign up to receive the latest short interest report for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHKMPF Short Interest Over TimeHKMPF Days to Cover Over TimeHKMPF Percentage of Float Shorted Over Time Ad True Market Insiders4 Cryptos BETTER than BitcoinFormer Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Hikma Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,849,700 shares $41.30 million +6.2%N/A9248.5 $22.33 4/15/20241,741,900 shares $42.24 million 0.0%N/A5806.3 $24.25 3/31/20241,742,100 shares $40.71 million +0.2%N/A8710.5 $23.37 3/15/20241,739,000 shares $40.64 million 0.0%N/A8695 $23.37 2/29/20241,739,100 shares $46.09 million +0.1%N/A5797 $26.50 2/15/20241,737,700 shares $43.44 million -1.2%N/A2172.1 $25.00 Get the Latest News and Ratings for HKMPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hikma Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,756,000 shares $43.30 million No ChangeN/A8780 $24.66 12/31/20231,756,000 shares $40.01 million -10.0%N/A2676.8 $22.79 12/15/20231,951,100 shares $43.02 million +0.1%N/A19511 $22.05 11/30/20231,948,900 shares $42.95 million +0.3%N/A721.8 $22.04 11/15/20231,944,100 shares $43.28 million +0.5%N/A4860.3 $22.26 10/31/20231,934,300 shares $45.24 million +4.5%N/A4835.8 $23.39 10/15/20231,850,400 shares $46.97 million +5.5%N/A9252 $25.38 9/30/20231,754,100 shares $47.36 million -1.1%N/A17541 $27.00 9/15/20231,774,300 shares $47.91 million -0.1%N/A17743 $27.00 8/31/20231,775,300 shares $47.93 million +0.1%N/A1894.6 $27.00 8/15/20231,774,500 shares $46.94 million +0.1%N/A4436.3 $26.45 7/31/20231,773,300 shares $46.90 million +13.1%N/A479.3 $26.45 7/15/20231,567,500 shares $36.24 million 0.0%N/A1045 $23.12 6/30/20231,567,700 shares $36.21 million -8.0%N/A7838.5 $23.10 6/15/20231,703,900 shares $40.89 million +0.4%N/A8519.5 $24.00 5/31/20231,697,100 shares $39.03 million -0.3%N/A5657 $23.00 5/15/20231,702,000 shares $38.96 million -0.7%N/A17020 $22.89 4/30/20231,714,200 shares $39.72 million +0.4%N/A2857 $23.17 4/15/20231,707,400 shares $35.24 million +11.9%N/A17074 $20.64 3/31/20231,526,500 shares $30.94 million -2.7%N/A1908.1 $20.27 3/15/20231,569,000 shares $32.38 million -0.2%N/A2241.4 $20.64 2/28/20231,571,400 shares $33.20 million +0.3%N/A3928.5 $21.13 2/15/20231,567,000 shares $32.67 million -0.9%N/A3134 $20.85 1/31/20231,580,400 shares $29.82 million +0.6%N/A0 $18.87 1/15/20231,571,500 shares $29.65 million -0.6%N/A0 $18.87 12/30/20221,581,500 shares $29.84 million +0.0%N/A3953.8 $18.87 12/15/20221,581,200 shares $29.84 million -0.1%N/A15812 $18.87 11/30/20221,582,800 shares $22.62 million -0.3%N/A3165.6 $14.29 11/15/20221,588,000 shares $22.69 million +0.3%N/A15880 $14.29 10/31/20221,582,900 shares $22.62 million +0.2%N/A3165.8 $14.29 10/15/20221,579,400 shares $22.55 million +0.4%N/A493.6 $14.28 9/30/20221,572,800 shares $21.64 million +0.2%N/A1966 $13.76 9/15/20221,569,100 shares $23.32 million +114.5%N/A412.9 $14.86 8/31/2022731,700 shares $10.87 million No ChangeN/A385.1 $14.86Global crypto currency reset (41 major banks signed up) (Ad)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. HKMPF Short Interest - Frequently Asked Questions What is Hikma Pharmaceuticals' current short interest? Short interest is the volume of Hikma Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 1,849,700 shares of HKMPF short. Learn More on Hikma Pharmaceuticals' current short interest. What is a good short interest ratio for Hikma Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HKMPF shares currently have a short interest ratio of 9,248.0. Learn More on Hikma Pharmaceuticals's short interest ratio. Is Hikma Pharmaceuticals' short interest increasing or decreasing? Hikma Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 1,849,700 shares, an increase of 6.2% from the previous total of 1,741,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Hikma Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Hikma Pharmaceuticals: Aspen Pharmacare Holdings Limited (0.00%), Zealand Pharma A/S (0.89%), Orion Oyj (0.00%), Sino Biopharmaceutical Limited (0.20%), GN Store Nord A/S (0.00%), Ramsay Health Care Limited (0.00%), Nihon Kohden Co. (0.00%), Sonic Healthcare Limited (0.00%), Sysmex Co. (0.00%), Eurofins Scientific SE (0.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Hikma Pharmaceuticals stock? Short selling HKMPF is an investing strategy that aims to generate trading profit from Hikma Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hikma Pharmaceuticals? A short squeeze for Hikma Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HKMPF, which in turn drives the price of the stock up even further. How often is Hikma Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HKMPF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: APNHY Short Squeeze ZLDPF Short Squeeze ORINY Short Squeeze SBMFF Short Squeeze GNNDY Short Squeeze AMFPF Short Squeeze RMYHY Short Squeeze NHNKY Short Squeeze SKHHY Short Squeeze RCDTF Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HKMPF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club